Roland W. Herzog
Heidelberg University · 369 works · 16,965 citations · h-index 68
Top works
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
- Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
- Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
- AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
- Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
- Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX Into Mouse Liver
- Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
- Progress and prospects: immune responses to viral vectors
- Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in Males
- Immune Responses to Viral Gene Therapy Vectors
- Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model
- Muscle-Directed Gene Transfer and Transient Immune Suppression Result in Sustained Partial Correction of Canine Hemophilia B Caused by a Null Mutation
- Role of Vector in Activation of T Cell Subsets in Immune Responses against the Secreted Transgene Product Factor IX
- Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
- Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
- Posttranslational modifications of recombinant myotube-synthesized human factor IX
- Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer
- Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
- Risk and Prevention of Anti-factor IX Formation in AAV-Mediated Gene Transfer in the Context of a Large Deletion of F9